ask="0.5922"
ask_size="900"
average_daily_volume="820358"
bid="0.5499"
bid_size="300"
book_value="-0.4130"
change="+0.0999"
change_from_200_day_moving_average="-0.1607"
change_from_50_day_moving_average="-0.0746"
change_from_52_week_high="-0.9601"
change_From_52_week_low="0.2897"
change_in_percent="+22.2000%"
close="0.5499"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.0830"
ebitda="-1.60M"
eps_estimate_current_year="-0.0800"
eps_estimate_next_quarter="0.0000"
eps_estimate_next_year="-0.0300"
ex_dividend_date="N/A"
float_shares="133560000"
high="0.5904"
high_52_weeks="1.5100"
last_trade_date="1/31/2017"
last_trade_price="0.5499"
last_trade_size="2131"
last_trade_time="4:02pm"
low="0.4900"
low_52_weeks="0.2602"
market_capitalization="85.51M"
moving_average_200_day="0.7106"
moving_average_50_day="0.6245"
name="Navidea Biopharmaceuticals
Inc"
notes="N/A"
one_year_target_price="1.2500"
open="0.5000"
pe_ratio="N/A"
peg_ratio="0.0000"
percent_change_from_200_day_moving_average="-22.6129%"
percent_change_from_50_day_moving_average="-11.9519%"
percent_change_from_52_week_high="-63.5828%"
percent_change_from_52_week_low="+111.3374%"
previous_close="0.4500"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="N/A"
price_per_sales="3.0545"
revenue="22.91M"
shares_outstanding="155494000"
short_ratio="17.2000"
stock_exchange="ASE"
symbol="NAVB"
volume="1088782"
weeks_range_52="0.2602 - 1.5100"
